Categories
- Anatomy
- Biochemistry
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Cardiology
- Cell Medicine
- Cell Therapy
- Chemistry
- DNA
- Embryology
- Future Medicine
- Gene Medicine
- Gene Therapy
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Human Genetics
- IVF Treatment
- Longevity Medicine
- Medical News
- Medical School
- Medical Technology
- Medicine
- Molecular Genetics
- Molecular Medicine
- Nano Medicine
- Nanotechnology
- Pet Stem Cell Therapy
- Stem Cell Therapy
Archives
Popular Search Keywords
Tag Archives: myriad-genetics
Genetics co. stock up after Jolie’s testing
A Utah-based genetics testing firm saw its shares rise yesterday after A-list actress Angelina Jolie went public with her preventive double mastectomy. While Jolie, 37, did not disclose the maker of the test that showed she had a BRCA1 gene mutation and thus an 87 percent risk of getting breast cancer Myriad Genetics holds patents on two genes linked to the disease. Its close to 100 percent (Jolie) took a Myriad test, said Kristen Shannon, director of genetic counseling at Massachusetts General Hospital Continue reading
Posted in Genetics
Tagged a-price-tag, angelina-jolie, blood-or-saliva, DNA, england, generated, laboratory, myriad, myriad-genetics, nature-or-the, rogers, supreme-court, while-jolie
Comments Off
Myriad Genetics to Present at the Bank of America Merrill Lynch Health Care Conference
SALT LAKE CITY, May 14, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. Continue reading
Posted in Genetics
Tagged america, america-merrill, and-recurrence-, city, decision-making, encore, generated, Genetics, guide-treatment, health, health-care, lake, myriad-genetics, pacific-on-may, present-at-the
Comments Off
Myriad Genetics rises on 3Q and stronger outlook
NEW YORK (AP) — Shares of Myriad Genetics Inc. rose Wednesday after the test maker reported a stronger profit and higher sales in the first quarter and raised its estimates for the full year Continue reading
Posted in Genetics
Tagged analysts, estimates, holds-on-genes, implies-revenue, myriad, myriad-genetics, patenting, sales, supreme, supreme-court, trademark
Comments Off
Myriad Genetics Announces 2013 Analyst and Investor Day
SALT LAKE CITY, May 2, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (MYGN) announced today that its Analyst and Investor Day for research analysts and institutional investors will take place on Thursday, May 9, 2013 at 9:00 a.m. Continue reading
Posted in Genetics
Tagged analyst, announced-today, archived-on-the, city, completion, generated, investor, lake, myriad-genetics, presentation
Comments Off
let the market decide!: the future of myriad genetics- will it stay a monopoly? – Video
let the market decide!: the future of myriad genetics- will it stay a monopoly? http://www.forbes.com/sites/stevensalzberg/2013/04/13/myriad-genetics-ceo-owns-your-genes/ By: lumbia33 Continue reading
Posted in Genetics
Tagged future, generated, let-the, market, market-decide, myriad-genetics, the-future, will-it-stay
Comments Off
6 Ways Gene Patent Case Could Impact Biotechnology
The Supreme Court heard oral arguments today (April 15) in a case to decide whether human genes can be patented. Continue reading
Posted in Biotechnology
Tagged a-better-test, a-patent-law, building-blocks, decide-whether, DNA, generated, genetic-test, harvard-medical, myriad-genetics, myriad-patent, opinion-on-test, oskar-liivak, school, supreme-court
Comments Off
U.S. Supreme Court looks at who should own DNA
WASHINGTON — DNA may be the building block of life, but can something taken from it also be the building block of a multimillion-dollar medical monopoly? Continue reading
Posted in DNA
Tagged a-novel-device, down-or-cripple, impact-on-other, karuna-jagger, myriad, myriad-genetics, patents, supreme-court, trademark, university
Comments Off
Designer Genes: Court to Weigh DNA Patents
Soon after learning that his son had autism, Hollywood producer Jon Shestack (“Air Force One”) tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder. But his approach to scientists at universities across the country in the late 1990s hit a brick wall: They refused to join forces, much less share the DNA. “Each thought they needed to hold on to it to publish and patent,” Shestack said in an interview Continue reading
Posted in DNA
Tagged a-brick-wall, country, generated, human, liberties-union, medical, myriad-genetics, public-patent, retirement, supreme, supreme-court, trademark, weill-cornell
Comments Off
The Supreme Court should invalidate the patent on human DNA
Jeffrey Rosenfeld is an assistant professor of medicine at the New Jersey Medical School and a member of the High Performance and Research Computing Group. Christopher E. Continue reading
Posted in DNA
Tagged a-lower-federal, a-lower-level, a-new-invention, a-single-gene, genetic, human, medical, myriad-genetics, school, supreme-court
Comments Off
Myriad Genetics Partners With PharmaMar For New HRD Test – Quick Facts
By RTT News, March 26, 2013, 04:41:00 PM EDT (RTTNews.com) – Myriad Genetics, Inc. ( MYGN ) on Tuesday revealed that it signed an agreement with PharmaMar, a marine-derived drug developer to test its homologous recombination deficiency or HRD test on patients who were part of PharmaMar’s Phase II clinical study of PM1183, the company’s drug candidate Continue reading
Posted in Genetics
Tagged agreement-with, chief-executive, first-publicly, inability, myriad, myriad-genetics, partnership-, peter-meldrum-, pharma, president, test-accurately, with-the-new, working-closely
Comments Off
Myriad Genetics Win on Gene Patent Ownership Is Appealed
Myriad Genetics Inc. (MYGN)s Australian court victory recognizing its ownership of patents for genes linked to cancer risks will be appealed by a group representing cancer patients, a law firm said Continue reading
Posted in Genetics
Tagged diseases, DNA, genomic-health, life, medical, myriad-genetics, such-as-genomic, sydney
Comments Off
Myriad Genetics Wins Australian Bid to Patent Human Genes
Myriad Genetics Inc., owner of patents related to genes linked to hereditary cancer risks, won an Australian court ruling allowing it to patent isolated DNA, a first in the country, ahead of a U.S. Supreme Court hearing on a similar case Continue reading
Posted in Genetics
Tagged australian, court-ruling, DNA, generated, genes-linked, Genetics, myriad-genetics, patent-isolated, similar-case-, supreme-court, the-country-
Comments Off
Myriad Genetics to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013
SALT LAKE CITY, Jan. 15, 2013 (GLOBE NEWSWIRE) — Myriad Genetics, Inc Continue reading
Posted in Genetics
Tagged a-live-webcast, call, call-on-tuesday, chief-executive, chief-financial, financial, Genetics, lake, myriad-genetic, myriad-genetics, peter-meldrum-, president, united, webcast-at-www
Comments Off
The Zacks Analyst Blog Highlights: Myriad Genetics, Sanofi, Abbott Laboratories, Johnson & Johnson and AstraZeneca
For Immediate Release Chicago, IL December 12, 2012 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Continue reading
Posted in Genetics
Tagged analyst, association, cardiovascular, companion, financial, hamilton-health, health-research, johnson, myriad-genetics, protein, zacks-equity
Comments Off
Professor Robin Feldman on Myriad – Video
Professor Robin Feldman on Myriad The US Supreme Court has granted review in Association for Molecular Pathology v. Myriad Genetics on the specific question, “Are human genes patentable?” UC Hastings College of the Law Professor Robin Feldman discusses that question, plus the “quartet of Supreme Court patent law decisions” that she believes may soon become a “quintet.” Professor Robin Feldman's work is widely regarded as some of the most influential scholarship in the field of patent law. She offered significant commentary to multiple media outlets during the Apple v Continue reading
Posted in Genetics
Tagged apple, are-available, association, feldman, genetics-on-the, multiple-media, myriad-genetics, patent-lawsuit, press, professor, professor-robin, supreme, the-specific, widely-regarded
Comments Off
Myriad Genetics slips on Supreme Court review
NEW YORK (AP) Shares of Myriad Genetics Inc. declined Monday after the U.S. Supreme Court agreed to hear a challenge to the practice of issuing patents on human genes. Continue reading
Posted in Genetics
Tagged a-test-designed, DNA, federal, generated, government, groups, monday-myriad, myriad-genetics, patents, practice, supreme, test, trademark, york
Comments Off
Gene Patents Draw High Court Review in Biotechnology Test
The U.S. Supreme Court agreed to consider whether human genes can be patented, taking up an issue that has split the medical community and will shape the future of personalized health care and the biotechnology industry. The justices today said they will hear a challenge to Myriad Genetics Inc. Continue reading
Posted in Biotechnology
Tagged a-higher-risk, a-person-has, Biotechnology, body, coding, congress, federal-circuit, generated, myriad-genetics, patents, research, supreme-court, technology-, united-states
Comments Off